These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27173519)

  • 1. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases.
    Zhang D; Chen B; Wang Y; Xia P; He C; Liu Y; Zhang R; Zhang M; Li Z
    Sci Rep; 2016 May; 6():25957. PubMed ID: 27173519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
    Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-Specific IgG Fc Glycosylation Ratios as Personalized Biomarkers to Differentiate Non-Small Cell Lung Cancer from Benign Lung Diseases.
    Zhang D; Li X; Liu X; Wang Y; Zhang M; Wang Q; Chen T; Li Z
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900016. PubMed ID: 31707769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of fucosylated IgG2 Fc-glycoforms in pancreatitis and pancreatic adenocarcinoma: a promising disease-classification model.
    Chen G; Li H; Qiu L; Qin X; Liu H; Li Z
    Anal Bioanal Chem; 2014 Jan; 406(1):267-73. PubMed ID: 24190616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
    J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.
    Baković MP; Selman MH; Hoffmann M; Rudan I; Campbell H; Deelder AM; Lauc G; Wuhrer M
    J Proteome Res; 2013 Feb; 12(2):821-31. PubMed ID: 23298168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in IgG1 Fc N-linked glycosylation in human lung cancer: age- and sex-related diagnostic potential.
    Chen G; Wang Y; Qin X; Li H; Guo Y; Wang Y; Liu H; Wang X; Song G; Li F; Li F; Guo S; Qiu L; Li Z
    Electrophoresis; 2013 Aug; 34(16):2407-16. PubMed ID: 23766031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum disease-specific IgG Fc glycosylation as potential biomarkers for nonproliferative diabetic retinopathy using mass spectrometry.
    Zhang Y; Lai Z; Yuan Z; Qu B; Li Y; Yan W; Li B; Yu W; Cai S; Zhang H
    Exp Eye Res; 2023 Aug; 233():109555. PubMed ID: 37364630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Selman MH; McDonnell LA; Palmblad M; Ruhaak LR; Deelder AM; Wuhrer M
    Anal Chem; 2010 Feb; 82(3):1073-81. PubMed ID: 20058878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
    de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
    J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
    Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
    Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic Acid Derivatization for the Rapid Subclass- and Sialic Acid Linkage-Specific MALDI-TOF-MS Analysis of IgG Fc-Glycopeptides.
    de Haan N; Reiding KR; Wuhrer M
    Methods Mol Biol; 2017; 1503():49-62. PubMed ID: 27743358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer.
    Chen G; Wang Y; Qiu L; Qin X; Liu H; Wang X; Wang Y; Song G; Li F; Guo Y; Li F; Guo S; Li Z
    J Proteomics; 2012 Jun; 75(10):2824-34. PubMed ID: 22365975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
    Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
    Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue imaging and serum lipidomic profiling for screening potential biomarkers of thyroid tumors by matrix-assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry.
    Guo S; Qiu L; Wang Y; Qin X; Liu H; He M; Zhang Y; Li Z; Chen X
    Anal Bioanal Chem; 2014 Jul; 406(18):4357-70. PubMed ID: 24842401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia.
    Hirschberg D; Ekman B; Wahlberg J; Landberg E
    PLoS One; 2021; 16(2):e0247805. PubMed ID: 33635916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-specific haptoglobin-β chain N-glycosylation as biomarker to differentiate non-small cell lung cancer from benign lung diseases.
    Chen T; He C; Zhang M; Li X; Liu X; Liu Y; Zhang D; Li Z
    J Cancer; 2019; 10(23):5628-5637. PubMed ID: 31737099
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive analysis of human IgG Fc N-glycopeptides and construction of a screening model for colorectal cancer.
    Zou Y; Hu J; Jie J; Lai J; Li M; Liu Z; Zou X
    J Proteomics; 2020 Feb; 213():103616. PubMed ID: 31846768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.